East Cary Family Physicians

FEBRUARY 27, 2024

Insights from East Cary Family Physicians In this blog, we’re diving into one of the most prevalent health conditions worldwide: diabetes. With millions of individuals affected by this metabolic disorder, it’s crucial to understand its causes, symptoms, management, and prevention strategies. Whether you’re newly diagnosed, caring for someone with diabetes, or seeking to enhance your knowledge, this guide aims to provide valuable insights and practical tips.

Diabetes 52

Diabetes Management Family Physician Individual 52

The Clinical Problem Solvers

FEBRUARY 28, 2024

[link] Episode description: SLS team members Priyanka, Kirtan and Anna discuss a case of progressive renal dysfunction in a patient with recent weight loss, peripheral eosinophilia and organomegaly Featuring: Anna Fretz Kirtan Patolia Priyanka Athavale Schemas AKI Eosinophilia Download CPSolvers App here RLRCPSOLVERS Click here to view the weekly episode recap email!

Patients 52

Patients 52

FDA Law Blog

FEBRUARY 29, 2024

By Kurt R. Karst — Earlier this week, we posted Part 1 of our three-part series on U.S. Patent and Trademark Office (“PTO”) Patent Term Extension (“PTE”) decisions under 35 U.S.C. § 156, as added by the 1984 Hatch-Waxman Amendments, for certain FDA-regulated products. Part 1 focused on both the PTO’s historical and current (180-degree and unsupported change in position) on multiple PTEs.

Clinic 59

Clinic IT Provider Patient-Centered 59

Oasis Family Medicine

FEBRUARY 27, 2024

As you know, my goal is to provide you with the latest and greatest healthcare innovations and even some not-so-new-but-extremely-effective therapies available. Castor oil is just that - one that I highly recommend. Please read on for more insight into this ancient but amazingly effective oil. There's a lot of valuable information below, plus an opportunity to purchase this amazing oil at a discount ( full transparency - yes, I get an affiliate commission. ) Tired of stuffing your nightstand wit

IT 52

IT Provider Screening Physicals 52

Maine Academy of Family Physicians

MARCH 1, 2024

Time is of the essence - SPEAK OUT TODAY! Please take a minute to contact your state legislators and urge them to vote YES on LD 1215, "An Act to End the Sale of Flavored Tobacco Products". There is a vote coming up in the legislature this week or next. We are a few votes short of passage in the House. Those legislators who are wavering on the vote need to hear YOUR voice.

IT 52

IT 52

GeriPal

FEBRUARY 29, 2024

Summary Transcript Summary Please join Eric and Alex in person for the GeriPal pub crawl at the AAHPM/HPNA annual assembly in Phoenix, Thursday night 3/21 8PM. Starting bar TBD, look for the GeriPal post, and follow #HPMParty on Twitter to keep us as we crawl! ** Today we celebrate eight years, around 2 million listens, and 300 podcasts! Eric and I take questions from you, our listeners, about: why we podcast, our most controversial podcast, which podcast changed our practice, favorite song req

IT 126

IT Patient-Centered Illness Education 126

FDA Law Blog

FEBRUARY 28, 2024

By Mark A. Tobolowsky & Michelle L. Butler — On Friday, February 23, 2024, FDA announced its final decision to withdraw the approval of Pepaxto (melphalan flufenamide), which was approved in February 2021 in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-dir

IT 59

IT Clinic Provider Patients 59

FDA Law Blog

FEBRUARY 26, 2024

Hyman, Phelps & McNamara, P.C. (HP&M) proudly announces that Director Anne Walsh will be a featured panelist at the highly anticipated 2024 Women’s White Collar Defense Association (WWCDA®) Leadership Retreat and Annual Attorney Meeting. The event is set to take place from March 4-6, 2024, in San Francisco, California. This annual gathering, renowned for its influential speakers and dynamic networking opportunities, will see Ms.

Government 59

Government IT Medical 59

FDA Law Blog

FEBRUARY 26, 2024

By Sara W. Koblitz & Kurt R. Karst — While the Biologics Price Competition and Innovation Act (“BPCIA”) is inherently distinct from the Hatch-Waxman Act, many of the fundamental concepts FDA adopted as it enacted the Hatch-Waxman Act made their way into FDA’s implementation of the BPCIA. This of course, make sense—after decades of experience implementing the Hatch-Waxman, Congress and FDA had learned a few new tricks by 2009/2010.

IT 59

IT Provider Clinic Medical 59